Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4848 USD | -0.84% | -0.35% | -61.52% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.52% | 26.84M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- BIVI Stock
- News BioVie Inc.
- BioVie : B. Riley Raises BioVie's PT to $50 from $47 On Liver, Neurodegenerative, and Oncology Pipeline, Keeps Buy Rating